The top legal official in New Mexico has opened a criminal investigation targeting the Drug Enforcement Administration following accusations that federal agents deliberately monitored massive fentanyl shipments entering communities without intervention. Attorney General Raúl Torrez announced the probe Friday, focusing on claims that DEA personnel allowed hundreds of thousands of deadly pills to reach residents between 2023 and 2025 while building larger criminal cases. The inquiry will explore potential criminal charges, civil lawsuits, and structural changes to prevent similar conduct.
Torrez emphasized the gravity of the allegations in his public statement. Families who lost loved ones to fentanyl overdoses deserve transparency about what federal authorities knew and failed to prevent, he stated. The attorney general characterized the situation not as bureaucratic incompetence but as a fundamental betrayal of public trust. His office pledged to pursue every available legal remedy to hold responsible parties accountable.
Investigation emerges after whistleblower revelations surface publicly
The criminal probe follows recent reporting that exposed DEA agents repeatedly observing large-scale fentanyl shipments without seizure during active investigations. Current and former DEA personnel, including whistleblower David Howell, provided accounts suggesting the agency’s enforcement tactics prioritized long-term case development over immediate public safety. These sources indicated the approach may have violated Department of Justice operational guidelines.
One particularly alarming incident involved agents monitoring the delivery of 74,000 fentanyl pills to a mobile home park in Albuquerque without intervening. Federal personnel reportedly tracked exact pill counts and shipment details while the dangerous drugs entered local distribution networks. Governor Michelle Lujan Grisham called the allegations shocking, noting agents knew fatalities would result from pills reaching New Mexico communities.
Governor demands accountability from federal drug enforcement agency
Lujan Grisham requested the investigation earlier this week, expressing outrage at the alleged federal negligence. The governor stated bluntly that DEA knew people would die if these pills reached New Mexico communities, yet the agency allowed it anyway. She pointed to the human cost: hundreds of parents burying children and countless kids growing up without stable parents.
- DEA initially denied whistleblower allegations in public statements
- The agency later requested independent review by Justice Department Inspector General
- Operations occurred during deadliest drug epidemic in United States history
- Enforcement tactics conflicted with agency’s “One Pill Can Kill” public awareness campaign
The governor emphasized that federal authorities stood by while monitoring shipments, tallying pills, and watching deadly drugs hit the streets. Her administration is now partnering with state law enforcement to pursue accountability at every level.
DEA requests independent review amid mounting criticism
While the Drug Enforcement Administration initially rejected Howell’s allegations, the agency reversed course and requested an independent review by the Justice Department’s Office of the Inspector General. A Justice Department statement indicated the agency would implement practice improvements if the review identifies deficiencies. Officials expressed willingness to partner with Governor Lujan Grisham and state leaders to combat fentanyl distribution and protect residents.
The timing of these enforcement operations raises serious questions about agency priorities. The alleged conduct occurred as the DEA promoted its “One Pill Can Kill” campaign, warning the public that even minimal fentanyl exposure can prove fatal. Critics argue the disconnect between public messaging and enforcement tactics undermines agency credibility and endangered vulnerable populations.
State officials pursue multiple legal avenues against federal agency
Attorney General Torrez outlined a comprehensive legal strategy targeting the alleged misconduct. His office will examine criminal prosecution possibilities, explore civil litigation options, and seek structural reforms to prevent future incidents. The investigation represents an unusual confrontation between state and federal law enforcement agencies over drug enforcement methodology.
New Mexico faces devastating impacts from the opioid crisis, with fentanyl driving record overdose deaths statewide. The revelation that federal agents may have knowingly allowed substantial quantities of the deadly synthetic opioid into communities has intensified calls for accountability. State officials argue residents deserve answers about why agents prioritized building comprehensive criminal cases over preventing immediate harm to public health and safety.
